Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

- Stable Renal Transplant Recipients
- Terminated

Study Title: Comparative Bioavailability of Myfenaxֲ® and CellCeptֲ® in Kidney Transplant Patients

Teva Identifier: 116B8 | 2009-010562-31

ClinicalTrials.gov Identifier: NCT00991510

Study Status: Terminated

Trial Condition(s): Stable Renal Transplant Recipients

Interventions: Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: 08/01/2009 - 10/01/2010

Phase: Phase 4

Study Type

Interventional